Abstract
In 2005, Edward Boyden of Stanford University and Karl Deisseroth of MIT opened up a new field of research-optogenetics-that offered the potential to revolutionize the treatment of neurological conditions. Their quest to genetically encode brain cells to be photosensitive has unlocked a toolkit that researchers are adding to consistently, and the implications for neuroscience and neuroengineering are vast.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
